- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06923033
Aim 1: App for Reducing Cravings to Smoke
November 12, 2025 updated by: H. Lee Moffitt Cancer Center and Research Institute
Aim 1: Augmented Reality as an Adjunct to Quitline Counseling for Smoking Cessation
The aim of this study is to update a recently developed study-related smartphone application to reduce cravings to smoke to be an engaging, user-friendly treatment tool, and verify user satisfaction
Study Overview
Study Type
Interventional
Enrollment (Actual)
14
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Tampa, Florida, United States, 33612
- Moffitt Cancer Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- >18 years of age
- Daily smokers that have quit smoking within the past 3 months (Aim 1) or currently smoking ≥ 3 cigarettes per day for the past year (Aim 2)
- Functioning telephone number
- Owns a smart phone capable of supporting AR and willing to download the app
- Can speak, read and write in English
Exclusion Criteria:
- Has another household member already enrolled in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Aim 1: Update an existing smartphone App
An existing study app will be updated to be engaging, user-friendly treatment tool, and verify user satisfaction.
|
Participants will download a study app that will allow them to track smoking urges and abstinence.
Access to augmented reality will become available after 48 hours of self-reported abstinence.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
System Usability Scale (Aim 1)
Time Frame: At 1 week
|
Participants' perception of usability and learnability of the app will be measured using 10 items on a 5-point Likert scale.
Scores range from 0 to 100, with higher scores indicating better usability.
|
At 1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
User Satisfaction (Aim 1)
Time Frame: At 1 week
|
One Likert scale item will capture participants' satisfaction with the app.
The Likert scale is from 1 to 4, with higher score indicating greater satisfaction.
|
At 1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Christine Vinci, Moffitt Cancer Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 9, 2023
Primary Completion (Actual)
November 2, 2023
Study Completion (Actual)
November 2, 2023
Study Registration Dates
First Submitted
April 9, 2025
First Submitted That Met QC Criteria
April 9, 2025
First Posted (Actual)
April 11, 2025
Study Record Updates
Last Update Posted (Actual)
November 18, 2025
Last Update Submitted That Met QC Criteria
November 12, 2025
Last Verified
November 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- MCC-21980 Aim1
- R01DA055298 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
University of VirginiaRecruitingSmoking | Smoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking, Cigarette | Quitting SmokingUnited States
-
National Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Cigarette Smoking | Tobacco, SmokingUnited States
-
University GhentActive, not recruitingSmoking | Smoking Tobacco | Smoking Prevention | Smoking CigaretteBelgium
-
Medical University of South CarolinaCompletedSmoking | Smoking Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)CompletedSmoking Cessation | Smoking, Cigarette | Quitting SmokingUnited States
-
Maastricht University Medical CenterThe Investigative Desk; SEO Amsterdam Economics; IVO Research InstituteEnrolling by invitationSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsNetherlands
-
Jennifer Marler, MDCompletedSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsUnited States
-
Johns Hopkins UniversityNational Center for Advancing Translational Sciences (NCATS); Community Partnership...CompletedSmoking Cessation | Smoking Reduction | Smoking, TobaccoUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)Completed
Clinical Trials on Smartphone App
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnMalignant Solid Neoplasm | Sarcoma | Hodgkin Lymphoma | Non-Hodgkin Lymphoma | Central Nervous System NeoplasmUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; American...Active, not recruitingMalignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States
-
Population Health Research InstituteUniversity of British Columbia; Canadian Institutes of Health Research (CIHR); Childhood Obesity Foundation and other collaboratorsActive, not recruiting
-
University of WashingtonCompletedDepression | AnxietyUnited States
-
NYU Langone HealthNational Institutes of Health (NIH)Recruiting
-
University GhentCompletedSuicidal Ideation | Suicidal Behavior | Coping BehaviorBelgium
-
Hartford HospitalNational Institute of Mental Health (NIMH); Oui Therapeutics, Inc.CompletedSuicidal Ideation | Suicide, AttemptedUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Institute on Drug Abuse (NIDA)Recruiting
-
World BankDepartment for International Development, United Kingdom; Wits Reproductive... and other collaboratorsCompletedHIV Infections | Antiretroviral Therapy | Patient Compliance | Viral Load | Cell PhoneSouth Africa
-
Universitätsklinikum Hamburg-EppendorfUnknownMultiple Sclerosis, Chronic Progressive